Company Nemus Bioscience Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18/01/18 |
Director of Finance/CFO | - | 04/10/21 | |
Chief Tech/Sci/R&D Officer | 52 | 12/12/22 | |
Karam Takhar
IRC | Investor Relations Contact | - | - |
Rhea Williams
LAW | General Counsel | - | 06/10/21 |
Thomas S. Kim
LAW | General Counsel | - | - |
Tu Diep
PRN | Corporate Officer/Principal | 43 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 06/08/20 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21/07/21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 17/08/23 |
Paul Grayson
BRD | Director/Board Member | - | 17/08/23 |
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18/01/18 |
Keith Ward
BRD | Director/Board Member | 54 | 13/12/21 |
Deborah Charych
BRD | Director/Board Member | - | 13/02/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,067,907 | 26,079,747 ( 92.92 %) | 0 | 92.92 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |